• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit/AskCarlat AI
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Topics » General Psychiatry » Files

General Psychiatry

CYPROHEPTADINE (Periactin) Fact Sheet [G]

November 29, 2023

Cyproheptadine is sometimes effective in reversing SSRI-induced anorgasmia, but with continued use it could interfere with antidepressant efficacy. As-needed occasional use is the best strategy From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

METFORMIN (Glucophage, Glumetza, Riomet) Fact Sheet [G]

November 29, 2023

Metformin is a medication for type 2 diabetes that increases insulin sensitivity and decreases appetite. It’s somewhat effective for antipsychotic-induced weight gain (average of 3 kg weight loss) and might work better if started prophylactically as a way to prevent excessive weight gain in the first place. It’s quite safe and well tolerated (with some GI side effects) and is becoming a standard add-on treatment in patients taking clozapine or olanzapine. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DESVENLAFAXINE (Pristiq) Fact Sheet [G]

November 29, 2023

Desvenlafaxine is the active metabolite of venlafaxine, and it has some minor advantages in terms of drug interactions, ease of dosing, and longer half-life. One disadvantage is lack of FDA approval for anxiety disorders. At least for depression, since desvenlafaxine is now available in a low-cost generic version, some clinicians prefer it over venlafaxine XR. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

DEXTROAMPHETAMINE (Dexedrine, Dextrostat, Liquadd, ProCentra, Zenzedi) Fact Sheet [G]

November 29, 2023

Dextroamphetamine is the dextro-isomer of racemic amphetamine. It has a long history of safe use in children, and is available in short- and long-acting formulations as generics. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

METHYLPHENIDATE TRANSDERMAL (Daytrana) Fact Sheet [G]

November 29, 2023

Daytrana is helpful for kids who, for whatever reason, cannot use any of the wide variety of oral stimulant preparations. Otherwise, we don’t recommend it due to high cost, lag time for onset of effect, and the side effect of rash, which is pretty common and unpleasant. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

LITHIUM (Eskalith, Lithobid) Fact Sheet [G]

November 29, 2023

Lithium is the gold standard for bipolar disorder. It is more useful for euphoric mania than for mixed and rapid-cycling types of bipolar disorder, but it is effective for depressive episodes and maintenance treatment of bipolar disorder. It is also known for its antisuicide effects in bipolar and unipolar mood disorders. It is likely underprescribed due to side effect concerns—though most patients tolerate lithium quite well. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Akathisia

November 29, 2023

A sense of restlessness, causing the patient to appear fidgety, to have difficulty sitting still, and to rock from one leg to the other while standing. It can present as an inner sense of restlessness without obvious movement. Can lead to agitation and even suicidal ideation. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

MIXED AMPHETAMINE SALTS (Adderall, Adderall XR, Mydayis) Fact Sheet [G]

November 29, 2023

Adderall contains 75% dextroamphetamine and 25% levoamphetamine. This ratio of amphetamine isomers is effective but is probably the most abused and diverted of all prescription stimulants. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

FLUVOXAMINE (Luvox, Luvox CR) Fact Sheet [G]

November 29, 2023

Fluvoxamine is used less often due to twice-daily dosing, sedation, risk for drug interactions, and fewer data for uses other than OCD, even though it’s likely just as effective as other SSRIs. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

AMPHETAMINE (Adzenys XR, ODT, Dyanavel XR, Evekeo) Fact Sheet [G]

November 29, 2023

Amphetamine is a 50:50 racemic mixture of dextro- and levo-amphetamine. In clinical practice, the most commonly prescribed amphetamine is Adderall (mixed amphetamine salts; see fact sheet later in this chapter). Based on metaanalyses, amphetamines are clearly the most effective option in both children and adults with ADHD. That doesn’t mean they should always be the first choice, though. Methylphenidates are often better tolerated and have relatively less abuse potential. Several newer formulations of amphetamine may be helpful for patients who don’t like to swallow pills—but they come with a price tag. From Medication Fact Book for Psychiatric Practice, 7th Edition (2023).

Previous 1 2 … 16 17 18 19 20 21 22 23 24 … 29 30 Next
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CAM1e_3DCover_Spiral_sm.png

    Complementary and Alternative Medicine in Psychiatry: A Fact Book (2026) -

    Fact sheets for 67 treatments that fall outside conventional psychopharmacology.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • Andrew-Christensen-1.jpg
    Psychology and Social Work

    Treating Couples: Integrative Behavioral Couple Therapy — Balancing Acceptance and Change Andrew Christensen, PhD

    Dr. Andrew Christensen, distinguished research professor of psychology at UCLA and co-developer of Integrative Behavioral Couple Therapy (IBCT), explains how IBCT balances...

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.